Last update 04 Nov 2024
IM-83 (Imunopharm)
Last update 04 Nov 2024
Overview
Basic Info
Drug Type CAR-T |
Synonyms AntiGPC3 CART cell therapy (Imunopharm), IM83嵌合抗原受体T细胞（艺妙神州）, IM83 (Imunopharm) |
Target |
Mechanism GPC3 inhibitors(Glypican-3 inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with IM-83 (Imunopharm)Phase I Clinical Study to Evaluate the Safety and Efficacy of IM83 CAR-T Cells for the Treatment of Relapsed or Refractory Osteosarcoma
Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients Wirh Advanced Liver Tumors
评估IM83 CAR-T细胞治疗晚期肝癌的安全性和有效性的I期临床研究
[Translation] A phase I clinical study to evaluate the safety and efficacy of IM83 CAR-T cells in the treatment of advanced liver cancer
100 Clinical Results associated with IM-83 (Imunopharm)
Login to view more data
100 Translational Medicine associated with IM-83 (Imunopharm)
Login to view more data
100 Patents (Medical) associated with IM-83 (Imunopharm)
Login to view more data
100 Deals associated with IM-83 (Imunopharm)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteosarcoma, Recurrent | Phase 1 | CN | 15 Jun 2024 | |
| Refractory Osteosarcoma | Phase 1 | CN | 15 Jun 2024 | |
| Osteosarcoma | Phase 1 | CN | 30 May 2024 | |
| GPC3 Positive Hepatocellular Carcinoma | Phase 1 | CN | 04 Mar 2024 | |
| Liver Cancer | Phase 1 | CN | 24 Aug 2021 | |
| GPC3 Positive Neoplasms | IND Approval | CN | 28 Jun 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free